
Unity Biotechnology, Inc.
USD0.20
+0.10 (+92.77%)
CEO
Anirvan Ghosh
IPO Date
2018-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.28
Prev. Close
$0.10
Day Low
$0.20
Day High
$0.32
52W Low
$0.10
52W High
$3.10
Market Cap
$0.00B
Volume
3.36M
UNITY Biotechnology to Host Investor Call with Retinal Expert Robert Bhisitkul, M.D., Ph.D., to Discuss Recent Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease